Elsa

News

The FDA has rolled out its highly-touted generative AI tool, almost a month early, with a promise to reduce the time taken for regulatory reviews.

News

Lilly's retatrutide achieved weight loss of more than 30% at two years in a new trial, firming up its credentials as a next-generation obesity drug.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.